向医生提供结直肠癌筛查未依从提醒对患者参与粪便免疫化学检测筛查的影响:一项随机临床试验
该研究在法国西海岸801家全科诊所开展三组整群随机试验,比较向全科医生提供患者特异性未依从提醒、地区性一般提醒或不提供提醒对50-74岁平均风险成人参与结直肠癌粪便免疫化学检测筛查的影响。1年时,患者特异性提醒组参与率24.8%,一般提醒组21.7%,常规护理组20.6%;患者特异性提醒组较常规护理组提高4.2%,一般提醒组较常规护理组差异无统计学显著。
要点
- 患者特异性提醒组1年筛查参与率24.8%,常规护理组20.6%。
- 患者特异性提醒组较常规护理组参与率提高4.2%(95%CI 2.3%-6.2%)。
- 一般提醒组较常规护理组差异无统计学显著(1.1%,95%CI -0.6%至2.8%)。
核心结论
- 向照护平均风险成人的法国全科医生提供其未及时更新结直肠癌筛查的患者名单,与常规护理相比,在1年时使患者参与粪便免疫化学检测筛查出现小幅但显著的增加。
- 向全科医生提供关于地区结直肠癌筛查率的一般提醒,与常规护理相比未增加筛查率。
研究设计与样本
- 三组整群随机研究,于2015年7月14日至2016年7月14日在法国西海岸开展,801家全科诊所参与。
- 纳入50-74岁、结直肠癌平均风险且未及时更新筛查的成人患者;最终随访日期为2016年7月14日。
- 1482名随机分组全科医生(平均年龄53.4岁;女性576名[38.9%])中1446名参与;这些医生的33044名患者(平均年龄59.7岁;女性17949名[54.3%])中,31229名(94.5%)可获得1年随访。
主要发现
- 1年时,患者特异性提醒组24.8%(95%CI 23.4%-26.2%)、一般提醒组21.7%(95%CI 20.5%-22.8%)、常规护理组20.6%(95%CI 19.3%-21.8%)参与粪便免疫化学检测筛查。
- 患者特异性提醒组 vs 一般提醒组差异为3.1%(95%CI 1.3%-5.0%)。
- 患者特异性提醒组 vs 常规护理组差异为4.2%(95%CI 2.3%-6.2%)。
- 一般提醒组 vs 常规护理组差异为1.1%(95%CI -0.6%至2.8%),未达统计学显著。
关键数值与推荐
- 患者特异性提醒组:496名全科医生,对应10476名患者。
- 一般提醒组:495名全科医生,对应10606名患者。
- 常规护理组:455名全科医生,对应10147名患者。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Increasing participation in fecal screening tests is a major challenge in countries that have implemented colorectal cancer (CRC) screening programs. OBJECTIVE: To determine whether providing general practitioners (GPs) a list of patients who are nonadherent to CRC screening enhances patient participation in fecal immunochemical testing (FIT). DESIGN, SETTING, AND PARTICIPANTS: A 3-group, cluster-randomized study was conducted from July 14, 2015, to July 14, 2016, on the west coast of France, with GPs in 801 practices participating and involving adult patients (50-74 years) who were at average risk of CRC and not up-to-date with CRC screening. The final follow-up date was July 14, 2016. INTERVENTIONS: General practitioners were randomly assigned to 1 of 3 groups: 496 received a list of patients who had not undergone CRC screening (patient-specific reminders group, 10 476 patients), 495 received a letter describing region-specific CRC screening adherence rates (generic reminders group, 10 606 patients), and 455 did not receive any reminders (usual care group, 10 147 patients). MAIN OUTCOMES AND MEASURES: The primary end point was patient participation in CRC screening 1 year after the intervention. RESULTS: Among 1482 randomized GPs (mean age, 53.4 years; 576 women [38.9%]), 1446 participated; of the 33 044 patients of these GPs (mean age, 59.7 years; 17 949 women [54.3%]), follow-up at 1 year was available for 31 229 (94.5%). At 1 year, 24.8% (95% CI, 23.4%-26.2%) of patients in the specific reminders group, 21.7% (95% CI, 20.5%-22.8%) in the generic reminders group, and 20.6% (95% CI, 19.3%-21.8%) in the usual care group participated in the FIT screening. The between-group differences were 3.1% (95% CI, 1.3%-5.0%) for the patient-specific reminders group vs the generic reminders group, 4.2% (95% CI, 2.3%-6.2%) for the patient-specific reminders group vs the usual care group, and 1.1% (95% CI, -0.6% to 2.8%) for generic reminders group vs the usual care group. CONCLUSIONS AND RELEVANCE: Providing French GPs caring for adults at average risk of CRC with a list of their patients who were not up-to-date with their CRC screening resulted in a small but significant increase in patient participation in FIT screening at 1 year compared with patients who received usual care. Providing GPs with generic reminders about regional rates of CRC screening did not increase screening rates compared with usual care. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT02515344.
引用
- Rat C, Pogu C, Le Donné D, et al. Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial. JAMA. 2017. PMID: 28873160. doi:10.1001/jama.2017.11387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。